NCT06775340

Study of RSS0343 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis

Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of RSS0343 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis

• Status: Recruiting
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 252 (estimated)
• Sponsor: Jiangsu HengRui Medicine Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

Studies to evaluate the safety, tolerability, pharmacodynamics, and efficacy of RSS0343 tablets in patients with non-cystic fibrosis bronchiectasis

Conditions

• Adolescent Asthma

Interventions

Type	Name	Description
DRUG	RSS0343 Tabella	RSS0343 tablets, oral;

Timeline

• Start date: 2025-01-22
• Primary completion: 2027-11-01
• Completion: 2027-12-01
• First posted: 2025-01-15
• Last updated: 2025-05-13

Locations

1 site across 1 country: China